Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för David P Schenkein. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att David P Schenkein har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:DNLI / Denali Therapeutics Inc. | Director | 15 257 |
US:REGN / Regeneron Pharmaceuticals, Inc. | Director | 448 |
US:AGIO / Agios Pharmaceuticals, Inc. | Director | 126 242 |
US:BLUE / bluebird bio, Inc. | Director | 3 000 |
US:FMI / Foundation Medicine, Inc. | Director | 23 326 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av David P Schenkein. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp AGIO / Agios Pharmaceuticals, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i AGIO / Agios Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|---|---|---|---|
2019-11-13 | AGIO | Schenkein David P | 8 064 | 31,0000 | 8 064 | 31,0000 | 249 984 | 250 | 55.9300 | 201 036 | 80,42 |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i AGIO / Agios Pharmaceuticals, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av David P Schenkein som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 6 037 | 15 257 | 65,48 | ||||
2025-01-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 166 | 448 | 58,87 | ||||
2024-11-13 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
S - Sale | X | −32 312 | 9 220 | −77,80 | 32,87 | −1 062 095 | 303 061 |
2024-11-13 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
S - Sale | X | −27 129 | 41 532 | −39,51 | 32,09 | −870 570 | 1 332 762 |
2024-11-13 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
M - Exercise | 47 165 | 68 661 | 219,41 | 18,00 | 848 970 | 1 235 898 | |
2024-06-17 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 3 388 | 126 242 | 2,76 | ||||
2024-06-04 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 5 967 | 21 496 | 38,42 | ||||
2024-02-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | −57 471 | 122 854 | −31,87 | 34,89 | −2 005 163 | 4 286 376 | |
2024-02-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 57 471 | 180 325 | 46,78 | 31,64 | 1 818 382 | 5 705 483 | |
2024-02-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | −11 858 | 122 854 | −8,80 | 33,60 | −398 429 | 4 127 894 | |
2024-02-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 11 858 | 134 712 | 9,65 | 31,64 | 375 187 | 4 262 288 | |
2024-02-27 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | −20 411 | 122 854 | −14,25 | 33,19 | −677 441 | 4 077 524 | |
2024-02-27 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 20 411 | 143 265 | 16,61 | 31,64 | 645 804 | 4 532 905 | |
2024-02-27 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | −47 731 | 122 854 | −27,98 | 33,05 | −1 577 510 | 4 060 325 | |
2024-02-27 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 47 731 | 170 585 | 38,85 | 31,64 | 1 510 209 | 5 397 309 | |
2024-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 42 | 282 | 17,50 | ||||
2023-09-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 240 | 240 | |||||
2023-06-23 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 4 975 | 122 854 | 4,22 | ||||
2023-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 4 216 | 15 529 | 37,27 | ||||
2023-04-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | −16 363 | 117 879 | −12,19 | 22,85 | −373 895 | 2 693 535 |
2023-04-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | X | 16 363 | 134 242 | 13,88 | 9,05 | 148 085 | 1 214 890 |
2023-03-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | −20 000 | 117 879 | −14,51 | 22,15 | −443 000 | 2 611 020 |
2023-03-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | X | 20 000 | 137 879 | 16,97 | 9,05 | 181 000 | 1 247 805 |
2023-03-15 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | −1 667 | 117 879 | −1,39 | 22,72 | −37 874 | 2 678 211 |
2023-03-15 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | −18 333 | 119 546 | −13,30 | 22,47 | −411 943 | 2 686 199 |
2023-03-15 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | X | 20 000 | 137 879 | 16,97 | 9,05 | 181 000 | 1 247 805 |
2023-03-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | −20 000 | 117 879 | −14,51 | 25,37 | −507 400 | 2 990 590 |
2023-03-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | X | 20 000 | 137 879 | 16,97 | 9,05 | 181 000 | 1 247 805 |
2023-02-15 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | −20 000 | 117 879 | −14,51 | 28,62 | −572 400 | 3 373 697 |
2023-02-15 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | X | 20 000 | 137 879 | 16,97 | 9,05 | 181 000 | 1 247 805 |
2023-02-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | −3 300 | 117 879 | −2,72 | 29,88 | −98 604 | 3 522 225 |
2023-02-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | −16 700 | 121 179 | −12,11 | 29,22 | −487 974 | 3 540 850 |
2023-02-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | X | 20 000 | 137 879 | 16,97 | 9,05 | 181 000 | 1 247 805 |
2023-01-19 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | −1 034 | 117 879 | −0,87 | 29,49 | −30 493 | 3 476 252 |
2023-01-19 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | −18 966 | 118 913 | −13,76 | 28,82 | −546 600 | 3 427 073 |
2023-01-19 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | X | 20 000 | 137 879 | 16,97 | 9,05 | 181 000 | 1 247 805 |
2022-06-06 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 5 986 | 11 313 | 112,37 | ||||
2022-05-24 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock unit |
M - Exercise | −1 585 | 0 | −100,00 | ||||
2022-05-24 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 1 585 | 117 879 | 1,36 | ||||
2022-02-23 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock units |
M - Exercise | −2 775 | 0 | −100,00 | ||||
2022-02-23 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
F - Taxes | −758 | 116 294 | −0,65 | 29,08 | −22 043 | 3 381 830 | |
2022-02-23 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 2 775 | 117 052 | 2,43 | ||||
2021-06-04 |
|
4 | DNLI |
Denali Therapeutics Inc.
Stock Option (right to buy) |
A - Award | 6 222 | 6 222 | |||||
2021-06-04 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 2 074 | 5 327 | 63,76 | ||||
2021-06-03 |
|
4 | DNLI |
Denali Therapeutics Inc.
Restricted Stock Units |
M - Exercise | −3 253 | 0 | −100,00 | ||||
2021-06-03 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
M - Exercise | 3 253 | 3 253 | |||||
2021-06-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock units |
M - Exercise | −1 686 | 0 | −100,00 | ||||
2021-06-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 1 686 | 114 277 | 1,50 | ||||
2021-05-24 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Stock options (right to buy) |
A - Award | 8 888 | 8 888 | |||||
2021-05-24 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock unit |
A - Award | 1 585 | 1 585 | |||||
2021-02-24 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock units |
M - Exercise | −2 774 | 2 775 | −49,99 | ||||
2021-02-24 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
F - Taxes | −821 | 112 591 | −0,72 | ||||
2021-02-24 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 2 774 | 113 412 | 2,51 | ||||
2021-02-17 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock units |
M - Exercise | −8 125 | 0 | −100,00 | ||||
2021-02-17 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
F - Taxes | −2 540 | 110 638 | −2,24 | ||||
2021-02-17 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 8 125 | 113 178 | 7,73 | ||||
2020-12-23 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
S - Sale | X | −5 000 | 26 232 | −16,01 | 90,01 | −450 027 | 2 361 022 |
2020-12-23 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
S - Sale | X | −25 000 | 0 | −100,00 | 90,06 | −2 251 555 | |
2020-11-13 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
S - Sale | X | −30 000 | 25 000 | −54,55 | 70,05 | −2 101 590 | 1 751 325 |
2020-11-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
S - Sale | X | −10 000 | 55 000 | −15,38 | 60,03 | −600 310 | 3 301 705 |
2020-11-06 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
S - Sale | X | −10 000 | 65 000 | −13,33 | 50,18 | −501 830 | 3 261 895 |
2020-06-22 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 3 000 | 3 000 | |||||
2020-06-22 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 1 500 | 6 832 | 28,13 | ||||
2020-06-22 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 156 | 5 332 | 3,01 | ||||
2020-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Restricted Stock Units |
A - Award | 3 253 | 3 253 | |||||
2020-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Stock Option (right to buy) |
A - Award | 15 183 | 15 183 | |||||
2020-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock units |
A - Award | 1 686 | 1 686 | |||||
2020-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Stock options (right to buy) |
A - Award | 8 096 | 8 096 | |||||
2020-02-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
F - Taxes | −880 | 105 053 | −0,83 | 48,66 | −42 821 | 5 111 879 | |
2020-02-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock units |
M - Exercise | −2 775 | 5 549 | −33,34 | ||||
2020-02-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 2 775 | 105 933 | 2,69 | ||||
2020-02-19 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
F - Taxes | −2 534 | 103 158 | −2,40 | 52,01 | −131 793 | 5 365 248 | |
2020-02-19 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock units |
M - Exercise | −8 125 | 8 125 | −50,00 | ||||
2020-02-19 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 8 125 | 105 692 | 8,33 | ||||
2019-11-15 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
P - Purchase | 8 064 | 97 567 | 9,01 | 31,00 | 249 984 | 3 024 577 | |
2019-06-10 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 4 000 | 4 000 | |||||
2019-06-10 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 1 000 | 5 176 | 23,95 | ||||
2019-06-03 |
|
4 | DNLI |
Denali Therapeutics Inc.
Stock Option (right to buy) |
A - Award | 27 245 | 27 245 | |||||
2019-02-26 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Restricted stock units |
A - Award | 8 324 | 8 324 | |||||
2019-02-26 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
A - Award | 45 719 | 45 719 | |||||
2019-02-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
F - Taxes | −2 471 | 89 503 | −2,69 | 58,03 | −143 392 | 5 193 859 | |
2019-02-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Restricted stock units |
M - Exercise | −8 125 | 16 250 | −33,33 | ||||
2019-02-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 8 125 | 91 974 | 9,69 | ||||
2018-11-19 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
G - Gift | −1 000 | 270 772 | −0,37 | ||||
2018-09-12 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | −8 730 | 137 471 | −5,97 | ||||
2018-09-12 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 8 730 | 83 849 | 11,62 | 31,64 | 276 217 | 2 652 982 | |
2018-09-07 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | −2 500 | 146 201 | −1,68 | ||||
2018-09-07 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | −72 619 | 0 | −100,00 | ||||
2018-09-07 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 2 500 | 75 119 | 3,44 | 31,64 | 79 100 | 2 376 765 | |
2018-09-07 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 72 619 | 72 619 | 2,34 | 169 928 | 169 928 | ||
2018-06-22 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 4 000 | 4 000 | |||||
2018-06-22 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 1 000 | 4 176 | 31,49 | ||||
2018-06-15 |
|
4 | DNLI |
Denali Therapeutics Inc.
Stock Option (right to buy) |
A - Award | 27 830 | 27 830 | |||||
2018-06-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −108 | 72 619 | −0,15 | |||
2018-06-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −12 892 | 0 | −100,00 | |||
2018-06-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 0 | −100,00 | 96,91 | −9 691 | |
2018-06-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −3 190 | 100 | −96,96 | 96,40 | −307 516 | 9 640 |
2018-06-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −8 200 | 3 290 | −71,37 | 95,11 | −779 902 | 312 912 |
2018-06-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 510 | 11 490 | −11,62 | 94,37 | −142 499 | 1 084 311 |
2018-06-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 108 | 13 000 | 0,84 | 2,34 | 253 | 30 420 |
2018-06-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 12 892 | 12 892 | 0,47 | 6 027 | 6 027 | |
2018-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −23 471 | 12 892 | −64,55 | |||
2018-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −16 193 | 0 | −100,00 | |||
2018-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −5 962 | 0 | −100,00 | |||
2018-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −45 626 | 0 | −100,00 | 90,07 | −4 109 534 | |
2018-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 23 471 | 45 626 | 105,94 | 0,47 | 10 973 | 21 330 |
2018-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 16 193 | 22 155 | 271,60 | 0,30 | 4 898 | 6 702 |
2018-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 5 962 | 5 962 | 0,30 | 1 804 | 1 804 | |
2018-05-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −49 374 | 16 193 | −75,30 | |||
2018-05-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −299 | 0 | −100,00 | 92,03 | −27 517 | |
2018-05-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −9 301 | 299 | −96,89 | 91,60 | −851 972 | 27 388 |
2018-05-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −39 774 | 9 600 | −80,56 | 90,11 | −3 584 035 | 865 056 |
2018-05-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 49 374 | 49 374 | 0,30 | 14 936 | 14 936 | |
2018-05-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −13 000 | 65 567 | −16,55 | |||
2018-05-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −100 | 0 | −100,00 | 84,35 | −8 435 | |
2018-05-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −2 814 | 100 | −96,57 | 83,56 | −235 138 | 8 356 |
2018-05-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −10 086 | 2 914 | −77,58 | 82,88 | −835 928 | 241 512 |
2018-05-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 13 000 | 13 000 | 0,30 | 3 932 | 3 932 | |
2018-04-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −13 000 | 78 567 | −14,20 | |||
2018-04-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −2 113 | 0 | −100,00 | 79,49 | −167 962 | |
2018-04-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −3 390 | 2 113 | −61,60 | 78,59 | −266 420 | 166 061 |
2018-04-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −3 340 | 5 503 | −37,77 | 77,76 | −259 718 | 427 913 |
2018-04-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −2 600 | 8 843 | −22,72 | 76,40 | −198 640 | 675 605 |
2018-04-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 557 | 11 443 | −11,98 | 75,54 | −117 616 | 864 404 |
2018-04-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 13 000 | 13 000 | 0,30 | 3 932 | 3 932 | |
2018-03-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −13 000 | 91 567 | −12,43 | |||
2018-03-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −10 085 | 0 | −100,00 | 81,30 | −819 910 | |
2018-03-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −2 915 | 10 085 | −22,42 | 80,38 | −234 308 | 810 632 |
2018-03-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 13 000 | 13 000 | 0,30 | 3 932 | 3 932 | |
2018-02-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Restricted stock units |
A - Award | 24 375 | 24 375 | |||||
2018-02-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
A - Award | 97 500 | 97 500 | |||||
2018-02-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −13 000 | 104 567 | −11,06 | |||
2018-02-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −4 460 | 0 | −100,00 | 79,23 | −353 366 | |
2018-02-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −8 540 | 4 460 | −65,69 | 78,50 | −670 390 | 350 110 |
2018-02-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 13 000 | 13 000 | 0,30 | 3 932 | 3 932 | |
2018-01-30 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −23 572 | 117 567 | −16,70 | |||
2018-01-30 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −2 966 | 0 | −100,00 | 82,22 | −243 865 | |
2018-01-30 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −11 369 | 2 966 | −79,31 | 81,40 | −925 437 | 241 432 |
2018-01-30 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −9 237 | 14 335 | −39,19 | 80,35 | −742 193 | 1 151 817 |
2018-01-30 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 23 572 | 23 572 | 0,30 | 7 131 | 7 131 | |
2018-01-26 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −20 | 141 139 | −0,01 | |||
2018-01-26 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −20 | 0 | −100,00 | 80,01 | −1 600 | |
2018-01-26 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 20 | 20 | 0,30 | 6 | 6 | |
2018-01-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −13 533 | 141 159 | −8,75 | |||
2018-01-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −13 533 | 0 | −100,00 | 80,01 | −1 082 775 | |
2018-01-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 13 533 | 13 533 | 0,30 | 4 094 | 4 094 | |
2018-01-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −32 875 | 5 962 | −84,65 | |||
2018-01-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −32 875 | 0 | −100,00 | 80,01 | −2 630 329 | |
2018-01-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 32 875 | 32 875 | 0,30 | 9 945 | 9 945 | |
2018-01-25 |
|
4/A | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −6 000 | 38 837 | −13,38 | |||
2018-01-16 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −53 000 | 154 692 | −25,52 | |||
2018-01-16 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −6 597 | 0 | −100,00 | 74,80 | −493 456 | |
2018-01-16 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −10 914 | 6 597 | −62,33 | 74,11 | −808 837 | 488 904 |
2018-01-16 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −22 304 | 17 511 | −56,02 | 73,02 | −1 628 638 | 1 278 653 |
2018-01-16 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −13 185 | 39 815 | −24,88 | 71,77 | −946 287 | 2 857 523 |
2018-01-16 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 53 000 | 53 000 | 0,30 | 16 032 | 16 032 | |
2017-12-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Series A-1 Preferred Stock |
C - Conversion | −19 774 | 0 | −100,00 | ||||
2017-12-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Series A-1 Preferred Stock |
C - Conversion | −19 774 | 0 | −100,00 | ||||
2017-12-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Series A-1 Preferred Stock |
C - Conversion | −105 225 | 0 | −100,00 | ||||
2017-12-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Series A-1 Preferred Stock |
C - Conversion | −105 225 | 0 | −100,00 | ||||
2017-12-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
C - Conversion | 19 774 | 19 774 | |||||
2017-12-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
C - Conversion | 19 774 | 19 774 | |||||
2017-12-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
C - Conversion | 105 225 | 105 225 | |||||
2017-12-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
C - Conversion | 105 225 | 105 225 | |||||
2017-12-08 |
|
4 | DNLI |
Denali Therapeutics Inc.
Stock Option (right to buy) |
A - Award | 47 165 | 47 165 | |||||
2017-12-07 | 3 | DNLI |
Denali Therapeutics Inc.
Common Stock |
150 000 | ||||||||
2017-12-07 | 3 | DNLI |
Denali Therapeutics Inc.
Common Stock |
150 000 | ||||||||
2017-12-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −6 000 | 20 656 | −22,51 | |||
2017-12-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −400 | 0 | −100,00 | 62,08 | −24 832 | |
2017-12-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −5 600 | 400 | −93,33 | 61,51 | −344 456 | 24 604 |
2017-12-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 6 000 | 6 000 | 0,30 | 1 815 | 1 815 | |
2017-11-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −6 000 | 26 656 | −18,37 | |||
2017-11-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −4 260 | 0 | −100,00 | 63,32 | −269 743 | |
2017-11-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −942 | 4 260 | −18,11 | 64,64 | −60 891 | 275 366 |
2017-11-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −598 | 5 202 | −10,31 | 65,42 | −39 121 | 340 315 |
2017-11-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −200 | 5 800 | −3,33 | 66,75 | −13 350 | 387 150 |
2017-11-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 6 000 | 6 000 | 0,30 | 1 815 | 1 815 | |
2017-10-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −80 000 | 32 656 | −71,01 | |||
2017-10-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −80 000 | 0 | −100,00 | 70,14 | −5 611 200 | |
2017-10-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 80 000 | 80 000 | 0,30 | 24 200 | 24 200 | |
2017-10-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −6 000 | 112 656 | −5,06 | |||
2017-10-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −6 000 | 0 | −100,00 | 66,76 | −400 560 | |
2017-10-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 6 000 | 6 000 | 0,30 | 1 815 | 1 815 | |
2017-09-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −35 000 | 118 656 | −22,78 | |||
2017-09-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −35 000 | 0 | −100,00 | 67,12 | −2 349 200 | |
2017-09-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 35 000 | 35 000 | 0,30 | 10 588 | 10 588 | |
2017-09-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
G - Gift | −500 | 271 772 | −0,18 | ||||
2017-09-05 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −2 000 | 19 361 | −9,36 | ||||
2017-09-05 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −2 000 | 3 176 | −38,64 | 115,07 | −230 145 | 365 470 | |
2017-09-05 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 2 000 | 5 176 | 62,97 | 8,16 | 16 312 | 42 214 | |
2017-09-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −6 000 | 153 656 | −3,76 | |||
2017-09-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −6 000 | 0 | −100,00 | 62,20 | −373 200 | |
2017-09-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 6 000 | 6 000 | 0,30 | 1 815 | 1 815 | |
2017-08-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −24 000 | 159 656 | −13,07 | |||
2017-08-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −24 000 | 0 | −100,00 | 60,55 | −1 453 200 | |
2017-08-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 24 000 | 24 000 | 0,30 | 7 260 | 7 260 | |
2017-08-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −3 000 | 183 656 | −1,61 | |||
2017-08-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −3 000 | 0 | −100,00 | 55,12 | −165 360 | |
2017-08-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 000 | 3 000 | 0,30 | 908 | 908 | |
2017-07-06 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −3 000 | 186 656 | −1,58 | |||
2017-07-06 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −3 000 | 0 | −100,00 | 51,18 | −153 540 | |
2017-07-06 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 000 | 3 000 | 0,30 | 908 | 908 | |
2017-06-12 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 4 000 | 4 000 | |||||
2017-06-12 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 1 000 | 3 176 | 45,96 | ||||
2017-06-08 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −1 900 | 189 656 | −0,99 | |||
2017-06-08 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 900 | 0 | −100,00 | 50,02 | −95 038 | |
2017-06-08 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 1 900 | 1 900 | 0,30 | 575 | 575 | |
2017-06-08 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −1 100 | 191 556 | −0,57 | |||
2017-06-08 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 100 | 0 | −100,00 | 50,02 | −55 022 | |
2017-06-08 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 1 100 | 1 100 | 0,30 | 333 | 333 | |
2017-05-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −3 000 | 192 656 | −1,53 | |||
2017-05-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −3 000 | 0 | −100,00 | 50,06 | −150 180 | |
2017-05-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 000 | 3 000 | 0,30 | 908 | 908 | |
2017-04-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −3 000 | 195 656 | −1,51 | |||
2017-04-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −3 000 | 0 | −100,00 | 58,62 | −175 860 | |
2017-04-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 000 | 3 000 | 0,30 | 908 | 908 | |
2017-03-03 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | −5 000 | 21 361 | −18,97 | ||||
2017-03-03 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | −5 000 | 2 176 | −69,68 | 89,53 | −447 632 | 194 810 | |
2017-03-03 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 5 000 | 7 176 | 229,78 | 8,16 | 40 779 | 58 526 | |
2017-03-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −3 000 | 198 656 | −1,49 | |||
2017-03-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −3 000 | 0 | −100,00 | 50,47 | −151 410 | |
2017-03-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 000 | 3 000 | 0,30 | 908 | 908 | |
2017-02-23 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
A - Award | 142 900 | 142 900 | |||||
2017-02-17 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −6 000 | 201 656 | −2,89 | |||
2017-02-17 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −6 000 | 0 | −100,00 | 50,01 | −300 060 | |
2017-02-17 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 6 000 | 6 000 | 0,30 | 1 815 | 1 815 | |
2017-01-27 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
A - Award | 68 182 | 136 363 | 100,00 | ||||
2017-01-23 |
|
4/A | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 1 000 | 2 176 | 85,03 | ||||
2016-06-20 |
|
4 | FMI |
Foundation Medicine, Inc.
Common Stock |
A - Award | 12 075 | 23 326 | 107,32 | 19,93 | 240 655 | 464 887 | |
2016-06-03 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 4 000 | 4 000 | |||||
2016-06-03 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 1 000 | 1 000 | |||||
2016-02-18 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
A - Award | 102 000 | 997 501 | 11,39 | ||||
2016-01-11 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | −20 000 | 895 501 | −2,18 | ||||
2016-01-11 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 20 000 | 272 272 | 7,93 | 0,30 | 6 050 | 82 362 | |
2016-01-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | −10 000 | 915 501 | −1,08 | ||||
2016-01-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 10 000 | 252 272 | 4,13 | 0,30 | 3 025 | 76 312 | |
2016-01-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | −10 000 | 925 501 | −1,07 | ||||
2016-01-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 10 000 | 242 272 | 4,31 | 0,30 | 3 025 | 73 287 | |
2015-12-07 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
A - Award | 68 181 | 935 501 | 7,86 | ||||
2015-10-30 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −4 000 | 867 320 | −0,46 | |||
2015-10-30 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −4 000 | 232 272 | −1,69 | 80,26 | −321 040 | 18 642 151 |
2015-10-30 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 4 000 | 236 272 | 1,72 | 31,64 | 126 560 | 7 475 646 |
2015-08-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −7 299 | 871 320 | −0,83 | |||
2015-08-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −701 | 878 619 | −0,08 | |||
2015-08-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −8 000 | 232 272 | −3,33 | 110,60 | −884 800 | 25 689 283 |
2015-08-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 7 299 | 240 272 | 3,13 | 31,64 | 230 940 | 7 602 206 |
2015-08-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 701 | 232 973 | 0,30 | 0,30 | 212 | 70 474 |
2015-06-22 |
|
4 | FMI |
Foundation Medicine, Inc.
Common Stock |
A - Award | 5 997 | 11 251 | 114,14 | 32,23 | 193 283 | 362 620 | |
2015-06-08 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 7 500 | 7 500 | |||||
2015-06-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −6 500 | 232 272 | −2,72 | 120,67 | −784 355 | 28 028 262 |
2015-06-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −6 500 | 232 272 | −2,72 | 120,67 | −784 355 | 28 028 262 |
2015-05-28 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −8 929 | 85 582 | −9,45 | 120,05 | −1 071 926 | 10 274 119 |
2015-05-28 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
G - Gift | −190 | 94 511 | −0,20 | ||||
2015-05-13 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −2 093 | 94 701 | −2,16 | 110,03 | −230 293 | 10 419 951 |
2015-05-13 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −3 107 | 96 794 | −3,11 | 110,01 | −341 801 | 10 648 308 |
2015-05-11 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 300 | 99 901 | −1,28 | 101,32 | −131 716 | 10 121 969 |
2015-05-11 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −2 600 | 238 772 | −1,08 | 101,32 | −263 432 | 24 192 379 |
2015-05-11 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | −10 000 | 879 320 | −1,12 | ||||
2015-05-11 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 10 000 | 241 372 | 4,32 | 0,30 | 3 025 | 73 015 | |
2015-05-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −3 900 | 231 372 | −1,66 | 93,63 | −365 157 | 21 663 360 |
2015-04-15 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 300 | 101 201 | −1,27 | 100,03 | −130 039 | 10 123 136 |
2015-04-15 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −2 600 | 235 272 | −1,09 | 100,03 | −260 078 | 23 534 258 |
2015-04-14 |
|
4/A | FMI |
Foundation Medicine, Inc.
Common Stock |
U - Other | −25 996 | 5 254 | −83,19 | 50,00 | −1 299 800 | 262 700 | |
2015-04-14 |
|
4/A | FMI |
Foundation Medicine, Inc.
Common Stock |
U - Other | −25 996 | 5 254 | −83,19 | 50,00 | −1 299 800 | 262 700 | |
2015-04-14 |
|
4/A | FMI |
Foundation Medicine, Inc.
Common Stock |
U - Other | −25 996 | 5 254 | −83,19 | 50,00 | −1 299 800 | 262 700 | |
2015-04-09 |
|
4 | FMI |
Foundation Medicine, Inc.
Common Stock |
U - Other | −25 218 | 6 032 | −80,70 | 50,00 | −1 260 900 | 301 600 | |
2015-04-09 |
|
4 | FMI |
Foundation Medicine, Inc.
Common Stock |
U - Other | −25 218 | 6 032 | −80,70 | 50,00 | −1 260 900 | 301 600 | |
2015-04-09 |
|
4 | FMI |
Foundation Medicine, Inc.
Common Stock |
U - Other | −25 218 | 6 032 | −80,70 | 50,00 | −1 260 900 | 301 600 | |
2015-04-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −3 900 | 237 872 | −1,61 | 92,54 | −360 906 | 22 012 675 |
2015-03-09 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −2 600 | 102 501 | −2,47 | 110,16 | −286 416 | 11 291 510 |
2015-03-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
A - Award | 136 000 | 889 320 | 18,05 | ||||
2015-03-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −1 300 | 105 101 | −1,22 | 107,05 | −139 165 | 11 251 062 |
2015-03-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −6 500 | 241 772 | −2,62 | 107,05 | −695 825 | 25 881 693 |
2015-03-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | −25 000 | 753 320 | −3,21 | ||||
2015-03-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 25 000 | 248 272 | 11,20 | 0,30 | 7 562 | 75 102 | |
2015-02-13 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −684 | 106 401 | −0,64 | 120,31 | −82 292 | 12 801 104 |
2015-02-13 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −787 | 107 085 | −0,73 | 120,14 | −94 550 | 12 865 192 |
2015-02-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −3 900 | 107 872 | −3,49 | 114,31 | −445 809 | 12 330 848 |
2015-02-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −6 500 | 223 272 | −2,83 | 114,31 | −743 015 | 25 522 222 |
2015-01-06 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −6 500 | 111 772 | −5,50 | 110,08 | −715 520 | 12 303 862 |
2015-01-06 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −6 500 | 229 772 | −2,75 | 110,08 | −715 520 | 25 293 302 |
2014-12-22 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
P - Purchase | 1 176 | 1 176 | 85,00 | 99 960 | 99 960 | ||
2014-12-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −6 500 | 118 272 | −5,21 | 97,03 | −630 695 | 11 475 932 |
2014-12-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −6 500 | 118 272 | −5,21 | 97,03 | −630 695 | 11 475 932 |
2014-11-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −6 500 | 124 772 | −4,95 | 81,71 | −531 115 | 10 195 120 |
2014-11-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −6 500 | 124 772 | −4,95 | 81,71 | −531 115 | 10 195 120 |
2014-10-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −2 500 | 778 320 | −0,32 | |||
2014-10-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −6 500 | 131 272 | −4,72 | 60,07 | −390 455 | 7 885 509 |
2014-10-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −6 500 | 131 272 | −4,72 | 60,07 | −390 455 | 7 885 509 |
2014-10-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 2 500 | 255 772 | 0,99 | 0,30 | 756 | 77 371 |
2014-09-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | −30 000 | 780 820 | −3,70 | |||
2014-09-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −30 000 | 137 772 | −17,88 | 62,68 | −1 880 400 | 8 635 549 |
2014-09-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −30 000 | 137 772 | −17,88 | 62,68 | −1 880 400 | 8 635 549 |
2014-09-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 30 000 | 283 272 | 11,84 | 0,30 | 9 075 | 85 690 |
2014-09-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | −6 500 | 810 820 | −0,80 | ||||
2014-09-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −6 500 | 167 772 | −3,73 | 46,30 | −300 950 | 7 767 844 |
2014-09-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −6 500 | 167 772 | −3,73 | 46,30 | −300 950 | 7 767 844 |
2014-09-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 6 500 | 259 772 | 2,57 | 0,30 | 1 966 | 78 581 |
2014-08-12 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −2 265 | 174 272 | −1,28 | 40,17 | −90 985 | 7 000 506 |
2014-08-12 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −2 265 | 253 272 | −0,89 | 40,17 | −90 985 | 10 173 936 |
2014-08-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −4 235 | 176 537 | −2,34 | 39,17 | −165 885 | 6 914 954 |
2014-08-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | −4 235 | 255 537 | −1,63 | 39,17 | −165 885 | 10 009 384 |
2014-07-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 500 | 180 772 | −3,47 | 46,52 | −302 380 | 8 409 513 |
2014-07-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 500 | 259 772 | −2,44 | 46,52 | −302 380 | 12 084 593 |
2014-06-20 |
|
4 | FMI |
Foundation Medicine, Inc.
Stock Option (right to buy) |
A - Award | 13 385 | 13 385 | |||||
2014-06-12 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 7 500 | 7 500 | |||||
2014-04-08 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
A - Award | 54 546 | 817 320 | 7,15 | ||||
2014-03-27 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −25 000 | 762 774 | −3,17 | ||||
2014-03-27 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 25 000 | 266 272 | 10,36 | 0,30 | 7 562 | 80 547 | |
2014-03-12 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | −54 000 | 787 774 | −6,42 | ||||
2014-03-12 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 54 000 | 241 272 | 28,84 | 0,30 | 16 335 | 72 985 | |
2014-03-07 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 160 000 | 841 774 | 23,47 | ||||
2013-10-02 |
|
4 | FMI |
Foundation Medicine, Inc.
Series A Convertible Preferred Stock |
C - Conversion | −125 000 | 0 | −100,00 | ||||
2013-10-02 |
|
4 | FMI |
Foundation Medicine, Inc.
Series A Convertible Preferred Stock |
C - Conversion | −125 000 | 0 | −100,00 | ||||
2013-10-02 |
|
4 | FMI |
Foundation Medicine, Inc.
Common Stock |
C - Conversion | 31 250 | 31 250 | |||||
2013-10-02 |
|
4 | FMI |
Foundation Medicine, Inc.
Common Stock |
C - Conversion | 31 250 | 31 250 | |||||
2013-09-24 | 3 | FMI |
Foundation Medicine, Inc.
Common Stock |
31 250 | ||||||||
2013-07-23 | 3 | AGIO |
AGIOS PHARMACEUTICALS INC
Common Stock |
187 272 | ||||||||
2013-07-23 | 3 | AGIO |
AGIOS PHARMACEUTICALS INC
Common Stock |
187 272 |